ERBB2 and breast carcinoma: The 2011 St.Gallen breast cancer consensus also recommended that the IHC status of ER, PgR, HER2, and Ki67 could be used to approximately classify breast cancer into these subtypes, which can guide subsequent systemic treatment [6].